High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$8.7M
$8,657,405
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-11 | $723,662 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-11 | $62,065 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-02-11 | $481,225 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $113,242 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $676,554 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $192,294 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $152,788 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $447,900 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2026-01-14 | $39,381 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-10 | $42,885 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-10 | $758,279 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-10 | $706,493 | S | Form 4 |
|
APGE
S
Apogee Therapeutics, Inc.
HENDERSON MICHAEL THOMAS
• CEO
10b5-1 Sell
2025-12-04
$3,000,400Large
|
||||||
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-12-04 | $3,000,400Large | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-13 | $206,846 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-13 | $932,830 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-13 | $114,108 | S | Form 4 |
| APGE |
Apogee Therapeutics, Inc.
|
CEO
10b5-1 Sell
|
2025-11-13 | $6,452 | S | Form 4 |